News

With over 48,000 new cases diagnosed per year, lung cancer is the third most common cancer in the UK.

Testing rules for COVID-19 are set to be eased for those who test positive on a lateral flow test but are asymptomatic.

The companies share the goal of furthering knowledge around GPCR biology in immune cells in order to better understand a range of immune system disorders.

The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary cancer presented.

Pressure on care and NHS staff mounts with the spread of the latest Omicron variant of COVID-19.

In order to help to reduce transmission of the Omicron variant, measures have been instated in hospitals, including a ban on ward visitations.

Pfizer’s Paxlovid has a success rate of nearly 90% as a prophylaxis treatment against severe COVID-19 when administered shortly after the patient has been infected with the virus.

WHO officials remain cautious about claiming Omicron as a milder variant of the COVID-19 virus.

Government vaccine advisers have said vulnerable primary school children should be offered a low-dose of a COVID-19 vaccine.

With authorisation, Pfizer’s oral antiviral candidate Paxlovid is an investigational SARS-CoV-2 protease inhibitor could be prescribed at the first sign of COVID-19 infection.

Calls for booster vaccinations in order to combat the rising cases brought about by winter and the recent Omicron variant have intensified, in the midst of record case rates.

With approval, Saphnelo would be the first available treatment for systematic lupus erythematosus in Europe in over ten years.

The DETERMINE trial aims to discover whether existing ‘licensed’ drugs could also benefit patients with rare cancer types that the drug is not currently licensed for.

It is estimated that chronic kidney disease affects more than 160 million people with type 2 diabetes worldwide.

Tetris Pharma’s Ogluo is the first ready-to-use, pre-mixed and pre-measured glucagon injection.